BioAmber

Canaccord Genuity acts as lead bookrunner on US$35 million confidentially marketed public offering by BioAmber

Canaccord Genuity is pleased to announce that on May 1, 2015, it completed an underwritten registered offering of common shares for BioAmber Inc. (NYSE: BIOA). BioAmber issued a total of 3,900,000 shares of its common stock at a price of $9.00 per share, raising net proceeds of approximately US$35.1 million. Canaccord Genuity acted as lead bookrunner on the offering.

BioAmber (NYSE: BIOA) is an industrial biotechnology company producing sustainable chemicals. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstock into sustainable chemicals for use in a wide variety of everyday products including plastics, paints, food additives and personal care products.